Test/Investigation
Liver blots (M2, M2(3EBPO), sp100, PML-1, gp210, LKM1, LC, SLA)
Site(s) or Laboratory offering Test/Investigation
NNUH (Immunology)
Units
N/A
Also Known as/Frequency of Test
AMA-M2, M2-3E(BPO), Sp100, PML, gp210, LKM-1, LC-1, SLA/LP and Ro52, Liver autoantibodies, Autoimmune screen
Indications
This immunoblot is performed in reflex to a significant IIF pattern on the Autoantibody test (e.g. SMA, AMA, LKM, LC1 pattern). Antibodies present are associated with autoimmune hepatitis I and II, primary biliary cirrhosis, sclerosing cholangitis
Comments/Precautions
Liver blots may be reflexed from results of an autoantibody screen
Sample type
Serum
Turnaround times (TAT) Urgent/Routine/GP or OPD
1 week
Reference intervals (adult unless stated)
Negative
If UKAS Accredited Test indicate at which site
Y NNUH